Begin Assessment Provider evaluation A licensed clinician reviews your profile and designs a personalized treatment plan
For patients with primarily dermal thinning and laxity without significant volume loss, polynucleotides remain the central treatment
Proactive monitoring, open conversations about emotional experience the goal remains integral patient care: treating the whole person, not just the symptom I would be very interested in reviewing the data supporting the claim that these medications may cause or increase the risk of anhedonia and depression
That familiar approach works at first, but as labs, symptoms, and dosing timelines accumulate, it fragments the story clinicians need to interpret results quickly
It can be used by most patients as a one-time treatment to lose unwanted weight, but it is also approved to help with long-term waste management under the care of a medical provider